Visceral leishmaniasis during pegylated interferon therapy for chronic hepatitis C: first report
- PMID: 16152764
Visceral leishmaniasis during pegylated interferon therapy for chronic hepatitis C: first report
Comment on
-
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?Antivir Ther. 2004 Aug;9(4):627-30. Antivir Ther. 2004. PMID: 15456094